You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diabetic kidney disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Kidney Disease Trial (Soleus ms exercise)

Not yet recruiting
  • Diabetic Kidney Disease
  • Soleus ms exercise
  • (no location specified)
Nov 4, 2023

Revealing Engagement Dynamics Among Diabetic Kidney Disease

Not yet recruiting
  • Diabetic Kidney Disease
    • San Francisco, California
      Power Life Sciences
    Oct 20, 2023

    Prevent Diabetic Kidney Disease Among Egyptians

    Not yet recruiting
    • Diabetes Mellitus Without Complication
    • (no location specified)
    Oct 6, 2023

    Thickening of Bowman's Capsule on Clinical Prognosis of Diabetic

    Not yet recruiting
    • Diabetic Kidney Disease
    • Extracellular Matrix Alteration
    • no intervention
    • (no location specified)
    Sep 15, 2023

    Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD

    Not yet recruiting
    • Diabetic Kidney Disease
    • cathepsin S and chromogranin A
    • (no location specified)
    Oct 5, 2023

    Diabetic Kidney Disease, Type 1 Diabetes Trial (Semaglutide, Placebo)

    Not yet recruiting
    • Diabetic Kidney Disease
    • Type 1 Diabetes
    • (no location specified)
    Apr 18, 2023

    Proteinuria, Kidney Dysfunction, Blood Pressure Trial in Hanzhou (Azilsartan, Losartan)

    Recruiting
    • Proteinuria
    • +3 more
    • Hanzhou, Zhejiang, China
      the Second Afficiated Hospital, Zhejiang University, School of M
    Feb 22, 2023

    Diabetic Kidney Disease, Diabetes Type 2, Chronic Kidney Diseases Trial

    Not yet recruiting
    • Diabetic Kidney Disease
    • +3 more
      • (no location specified)
      Nov 23, 2022

      Diabetic Kidney Disease Trial in Beijing (SPH3127+SPH3127matching +valsartan matching , SPH3127+valsartan matching , SPH3127

      Not yet recruiting
      • Diabetic Kidney Disease
      • SPH3127+SPH3127matching placebo+valsartan matching placebo
      • +2 more
      • Beijing, China
        Peking Union Medical College Hospital
      Jan 9, 2023

      Diabetic Kidney Disease Trial (INV-202, Placebo)

      Not yet recruiting
      • Diabetic Kidney Disease
      • (no location specified)
      Aug 22, 2022

      Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation

      Active, not recruiting
      • Diabetic Nephropathy
      • Grouping based on previous laboratory results, no intervention.
      • Jinan, Shandong, China
        Qianfoshan Hospital
      Nov 8, 2023

      Diabetic Kidney Disease Trial in Herlev (ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide,

      Recruiting
      • Diabetic Kidney Disease
      • ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
      • Herlev, Denmark
        Department of Nephrology, Herlev and Gentofte Hospital
      May 31, 2023

      Type2diabetes, Diabetic Kidney Disease Trial (Investigational Product - MIB 626, Placebo)

      Not yet recruiting
      • Type2diabetes
      • Diabetic Kidney Disease
      • Investigational Product - MIB 626
      • Placebo
      • (no location specified)
      Mar 6, 2023

      Diabetic Nephropathies Trial in Mansoura (Valsartan 80 mg, Empagliflozin 10 MG, Levocetirizine)

      Recruiting
      • Diabetic Nephropathies
      • Valsartan 80 mg
      • +2 more
      • Mansoura, Egypt
        Mansoura University
      Nov 28, 2022

      Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)

      Recruiting
      • Type2Diabetes
      • ASCVD
      • SGLT2 inhibitor
      • +2 more
      • New York, New York
      • +1 more
      Dec 19, 2022

      Diabetic Kidney Disease Trial in Sendai (Bardoxolone methyl, Placebo)

      Active, not recruiting
      • Diabetic Kidney Disease
      • Bardoxolone methyl
      • Placebo
      • Sendai, Miyagi, Japan
        Japan Community Health care Organization Sendai Hospital
      Jun 26, 2022

      Diabetic Kidney Disease, CAKUT, Chronic Kidney Diseases Trial (Renal Autologous Cell Therapy (REACT))

      Not yet recruiting
      • Diabetic Kidney Disease
      • +2 more
      • Renal Autologous Cell Therapy (REACT)
      • (no location specified)
      Jan 11, 2023

      A Long-Term Follow-Up Study of Participants Exposed to REACT

      Not yet recruiting
      • Diabetic Kidney Disease
      • Chronic Kidney Diseases
      • Renal Autologous Cell Therapy (REACT)
      • (no location specified)
      Jun 15, 2023

      Diabetic Kidney Disease Trial in Aurora (Montelukast)

      Recruiting
      • Diabetic Kidney Disease
      • Aurora, Colorado
        University of Colorado
      Aug 15, 2022

      Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)

      Not yet recruiting
      • Diabetic Kidney Disease
      • IgA Nephropathy
      • Placebo of SC0062
      • +3 more
      • (no location specified)
      Jan 9, 2023

      Diabetic Kidney Disease Trial in Taichung City (Probiotic group, Placebo group)

      Not yet recruiting
      • Diabetic Kidney Disease
      • Probiotic group
      • Placebo group
      • Taichung City, Taiwan
        Chung Shan Medical University Hospital
      Dec 29, 2022

      Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

      Recruiting
      • Kidney Disease
      • Chula Vista, California
      • +5 more
      Jan 23, 2023

      Diabetic Nephropathies, Diabetes, Type 2, Chronic Kidney Diseases Trial in Milwaukee (Individualized basic need navigation and

      Recruiting
      • Diabetic Nephropathies
      • +3 more
      • Individualized basic need navigation and lifestyle coaching and skills training
      • Enhanced usual care
      • Milwaukee, Wisconsin
        Medical College of Wisconsin
      Aug 24, 2022

      T2DM (Type 2 Diabetes), Metformin, SGLT2-Inhibitors Trial in Matsumoto (Tofogliflozin, Metformin)

      Recruiting
      • T2DM (Type 2 Diabetes Mellitus)
      • +2 more
      • Matsumoto, Nagano, Japan
        Shinshu University
      Jul 21, 2022

      Diabetic Nephropathies Trial in Tanta (Niclosamide, Placebo oral tablet)

      Completed
      • Diabetic Nephropathies
      • Tanta, Egypt
        Faculty of Pharmacy, Tanta University
      Oct 19, 2022